Hanmi Pharm Reports Operating Profit of 10.6 Billion KRW in Q2, Down 54% Year-on-Year
[Asia Economy Reporter Geum Bo-ryeong] Hanmi Pharm announced on the 29th that its consolidated operating profit for the second quarter of this year was preliminarily estimated at 10.64 billion KRW, down 54.1% compared to the previous year.
Hot Picks Today
"Buy on Black Monday"... Japan's Nomura Forecasts 590,000 for Samsung, 4 Million for SK hynix
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- With Pop Stars Flocking to Korea, $1.7 Billion Concert Market Emerges... Korea Becomes a ‘Must-Visit Hub’ for Asia Tours
- "Samsung and Hynix Were Once for the Underachievers"... Hyundai Motor Employee's Lament
- "That? It's Already Stashed" Nightlife Scene Crosses the Line [ChwiYak Nation] ③
During the same period, sales amounted to 243.411 billion KRW, a decrease of 10%.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
